BioMarin Pharmaceutical | BMRN - 股本和储备



金融业
股票价格
USD
资产
USD 8.59B
现金及等价物
USD 2.22B
销售成本
USD 199.48M
流动资产
USD 4.61B
流动负债
USD 793.15M
债务
USD 1.44B
EBIT
USD 129.65M
EBITDA
USD 146.05M
员工
3.04K
EPS每股收益
USD 0.76
股本和储备
USD 6.21B
销售毛利
USD 571.21M
债务利息支出
USD 14.96M
利息收入
USD 22.56M
贷款资金
USD 1.43B
市值
USD 10.42B
净收入
USD 105.53M
营业费用
USD 636.56M
营业利润
USD 129.65M
普通股股本
USD 193.27M
PE价格收益
15.28
税前利润
USD 141.2M
销售收入
USD 766M
销售和管理费用
USD 258.28M
股票
USD 1.27B
贸易债权人
USD 793.15M
应收帐款人
USD 903.91M


股本和储备 更改 日
Acadia Pharmaceuticals USD 1.25B 20.68M 2026-03
Agios Pharmaceuticals USD 1.11B 84M 2026-03
Alnylam Pharmaceuticals USD 1.08B 286.2M 2026-03
Amgen USD 9.19B 532M 2026-03
Bayer EUR 28.85B 2.9B 2026-03
Biogen USD 18.65B 394.9M 2026-03
BioMarin Pharmaceutical USD 6.21B 125.11M 2026-03
Gilead Sciences USD 23.52B 897M 2026-03
Incyte USD 5.62B 455.37M 2026-03
Insmed USD 704.85M 34.12M 2026-03
Ionis Pharmaceuticals USD 491.41M 2.32M 2026-03
Moderna USD 7.41B 1.24B 2026-03
Neurocrine Biosciences USD 3.41B 154.3M 2026-03
PTC Therapeutics USD -180.46M 24.85M 2026-03
Puma Biotechnology USD 115.27M 10.55M 2025-09
Regeneron Pharmaceuticals USD 31.42B 166.7M 2026-03
Roche Holding CHF 33.8B 758M 2025-12
Sangamo BioSciences USD 19.6M 14.7M 2025-06
Sanofi EUR 71.71B 14.25B 2025-12
Sarepta Therapeutics USD 1.51B 364.48M 2026-03
Ultragenyx Pharmaceutical USD -236M 156M 2026-03
United Therapeutics USD 5.9B 1.2B 2026-03
Vertex Pharmaceuticals USD 19.36B 696.1M 2026-03